AXOGEN INC. - COMMON STOCK
13.34
22-十一月-24 16:44:58
15 分钟延时
股票
+0.24
+1.83%
今日范围
12.99 - 13.40
ISIN
N/A
来源
NASDAQ
-
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
06 3月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
02 3月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
13 2月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
09 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
05 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
04 1月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
19 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 Third Quarter Financial Results
08 11月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Axogen to Participate at Upcoming Investor Conferences
03 11月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
31 10月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
20 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand
22 9月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 Second Quarter Financial Results
03 8月 2022 16:01:01 条件 Nasdaq GlobeNewswire
-
Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference
29 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
18 7月 2022 16:00:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc. Appoints William Burke to Board of Directors
11 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
18 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 First Quarter Financial Results
04 5月 2022 16:05:01 条件 Nasdaq GlobeNewswire
-
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft
04 5月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022
13 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire